Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ceribell Inc (CBLL)

Ceribell Inc (CBLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 702,757
  • Shares Outstanding, K 37,641
  • Annual Sales, $ 65,440 K
  • Annual Income, $ -40,460 K
  • EBIT $ -57 M
  • EBITDA $ -55 M
  • 60-Month Beta 1.03
  • Price/Sales 7.89
  • Price/Cash Flow N/A
  • Price/Book 4.52

Options Overview Details

View History
  • Implied Volatility 117.16% (+18.17%)
  • Historical Volatility 39.44%
  • IV Percentile 67%
  • IV Rank 37.27%
  • IV High 208.93% on 10/15/25
  • IV Low 62.64% on 03/03/25
  • Expected Move (DTE 19) 1.53 (8.19%)
  • Put/Call Vol Ratio 0.04
  • Today's Volume 59
  • Volume Avg (30-Day) 12
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 669
  • Open Int (30-Day) 635
  • Expected Range 17.14 to 20.20

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.39
  • Number of Estimates 4
  • High Estimate -0.38
  • Low Estimate -0.40
  • Prior Year -0.36
  • Growth Rate Est. (year over year) -8.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.79 +4.95%
on 02/25/26
21.95 -14.94%
on 02/11/26
-3.22 (-14.71%)
since 01/27/26
3-Month
16.27 +14.75%
on 12/01/25
24.33 -23.26%
on 01/12/26
+1.76 (+10.41%)
since 11/26/25
52-Week
10.01 +86.51%
on 04/10/25
24.68 -24.35%
on 03/04/25
-5.09 (-21.42%)
since 02/27/25

Most Recent Stories

More News
Ceribell Reports Fourth Quarter and Full Year 2025 Financial Results

SUNNYVALE, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 18.67 (-3.71%)
Ceribell to Participate in Upcoming March Investor Conferences

SUNNYVALE, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 18.67 (-3.71%)
Ceribell to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

SUNNYVALE, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 18.67 (-3.71%)
Ceribell Receives FDA Breakthrough Device Designation for LVO Stroke Detection and Monitoring Solution

SUNNYVALE, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 18.67 (-3.71%)
Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference

SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 18.67 (-3.71%)
Medical Breakthroughs: 5 AI Innovators Redefining What's Possible

Issued on behalf of VentriPoint Diagnostics Ltd. VANCOUVER – Baystreet.ca News Commentary – The healthcare AI market reached $21.66 billion in 2025 and analysts now project growth to $110.61...

CBLL : 18.67 (-3.71%)
ONMD : 1.0200 (+44.60%)
VPT.VN : 0.105 (unch)
LNAI : 0.3705 (-7.38%)
ABSI : 2.74 (-2.49%)
VPTDF : 0.0790 (+5.19%)
Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution

SUNNYVALE, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 18.67 (-3.71%)
Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 18.67 (-3.71%)
Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference

SUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 18.67 (-3.71%)
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

SUNNYVALE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with...

CBLL : 18.67 (-3.71%)

Business Summary

CeriBell Inc. is a commercial-stage medical technology company. It focused on transforming the diagnosis and management of patients with serious neurological conditions. The company is an AI-powered, rapidly deployable point-of-care electroencephalography platform designed to address the unmet needs...

See More

Key Turning Points

3rd Resistance Point 20.53
2nd Resistance Point 19.91
1st Resistance Point 19.29
Last Price 18.67
1st Support Level 18.05
2nd Support Level 17.42
3rd Support Level 16.80

See More

52-Week High 24.68
Fibonacci 61.8% 19.08
Last Price 18.67
Fibonacci 50% 17.35
Fibonacci 38.2% 15.61
52-Week Low 10.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar